#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat|salience|identity|centering
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent
#Summary1=(human1) After examining a 72 year old man (allergic to Vicodin) with chronic lymphocytic leukemia (CLL) since May 2008 and currently taking 5mg predinsone every other day, a physician reports he is suffering from autoimmune hemolytic anemia and oral ulcers on the lip and tongue, and puts him back on Valtrex and lowers steroids to 1mg daily ahead of a clinic visit the next week.
#Summary2=(claude-3-5-sonnet-20241022) 72-year-old male with chronic lymphocytic leukemia (diagnosed May 2008) and autoimmune hemolytic anemia on chronic steroids presents for follow-up with stable blood counts, oral ulcers after discontinuing antivirals, and plan to restart Valtrex and adjust steroid dosage.
#Summary3=(gpt4o) A 72-year-old man with chronic lymphocytic leukemia and autoimmune hemolytic anemia, on prednisone and other medications, presented with oral ulcers and visual issues, requiring follow-up and alteration of his steroid regimen, resumption of antiviral therapy, and a plan to review his condition in a week.
#Summary4=(Meta-Llama-3-8B-Instruct) A 72-year-old man with chronic lymphocytic leukemia and autoimmune hemolytic anemia reports an oral ulcer, night vision issues, and headaches, with stable blood counts on chronic steroids.
#Summary5=(Qwen2.5-3B-Instruct) A 72-year-old man with chronic lymphocytic leukemia and autoimmune hemolytic anemia discusses his ongoing treatment, including current medications and a plan to increase Valtrex use and decrease corticosteroid dosage.


#Text=Description :
1-1	0-11	Description	_	_	_	_	cf1[1]	_	_
1-2	12-13	:	_	_	_	_	_	_	_

#Text=Chronic lymphocytic leukemia ( CLL ) , autoimmune hemolytic anemia , and oral ulcer .
2-1	14-21	Chronic	abstract[285]	new[285]	_	Chronic_lymphocytic_leukemia[4]	cf2[3]|cf1[4]	coref	3-6[10_285]
2-2	22-33	lymphocytic	abstract[285]	new[285]	_	Chronic_lymphocytic_leukemia[4]	cf2[3]|cf1[4]	_	_
2-3	34-42	leukemia	abstract[285]	new[285]	_	Chronic_lymphocytic_leukemia[4]	cf2[3]|cf1[4]	_	_
2-4	43-44	(	abstract[285]	new[285]	_	_	cf2[3]	_	_
2-5	45-48	CLL	abstract[285]	new[285]	_	Chronic_lymphocytic_leukemia[5]	cf2[3]|cf1[5]	_	_
2-6	49-50	)	abstract[285]	new[285]	_	_	cf2[3]	_	_
2-7	51-52	,	_	_	_	_	cf2[3]	_	_
2-8	53-63	autoimmune	_	_	_	_	cf2[3]|cf3[7]	_	_
2-9	64-73	hemolytic	_	_	_	_	cf2[3]|cf3[7]	_	_
2-10	74-80	anemia	_	_	_	_	cf2[3]|cf3[7]	_	_
2-11	81-82	,	_	_	_	_	cf2[3]	_	_
2-12	83-86	and	_	_	_	_	cf2[3]	_	_
2-13	87-91	oral	_	_	_	_	cf2[3]|cf4[8]	_	_
2-14	92-97	ulcer	_	_	_	_	cf2[3]|cf4[8]	_	_
2-15	98-99	.	_	_	_	_	_	_	_

#Text=The patient was diagnosed with chronic lymphocytic leukemia and was noted to have autoimmune hemolytic anemia at the time of his CLL diagnosis .
3-1	100-103	The	person[9]	new[9]	sssss[9]	_	cf1[9]	ana	3-21[14_9]
3-2	104-111	patient	person[9]	new[9]	sssss[9]	_	cf1[9]	_	_
3-3	112-115	was	_	_	_	_	_	_	_
3-4	116-125	diagnosed	_	_	_	_	_	_	_
3-5	126-130	with	_	_	_	_	_	_	_
3-6	131-138	chronic	abstract[10]	giv:act[10]	sssss[10]	Chronic_lymphocytic_leukemia[10]	cf3[10]	coref	3-22[15_10]
3-7	139-150	lymphocytic	abstract[10]	giv:act[10]	sssss[10]	Chronic_lymphocytic_leukemia[10]	cf3[10]	_	_
3-8	151-159	leukemia	abstract[10]	giv:act[10]	sssss[10]	Chronic_lymphocytic_leukemia[10]	cf3[10]	_	_
3-9	160-163	and	_	_	_	_	_	_	_
3-10	164-167	was	_	_	_	_	_	_	_
3-11	168-173	noted	_	_	_	_	_	_	_
3-12	174-176	to	_	_	_	_	_	_	_
3-13	177-181	have	_	_	_	_	_	_	_
3-14	182-192	autoimmune	_	_	_	_	cf2*[11]	_	_
3-15	193-202	hemolytic	_	_	_	_	cf2*[11]	_	_
3-16	203-209	anemia	_	_	_	_	cf2*[11]	_	_
3-17	210-212	at	_	_	_	_	_	_	_
3-18	213-216	the	_	_	_	_	cf4[12]	_	_
3-19	217-221	time	_	_	_	_	cf4[12]	_	_
3-20	222-224	of	_	_	_	_	cf4[12]	_	_
3-21	225-228	his	abstract[13]|person[14]	new[13]|giv:act[14]	nnnnn[13]|sssss[14]	_	cf4[12]|cf5[13]|cf1[14]	coref|coref	9-1[26_14]|10-13[35_13]
3-22	229-232	CLL	abstract[13]|abstract[15]	new[13]|giv:act[15]	nnnnn[13]|sssss[15]	Chronic_lymphocytic_leukemia[15]	cf4[12]|cf5[13]|cf3[15]	_	_
3-23	233-242	diagnosis	abstract[13]	new[13]	nnnnn[13]	_	cf4[12]|cf5[13]	_	_
3-24	243-244	.	_	_	_	_	_	_	_

#Text=CHIEF COMPLAINT :
4-1	245-250	CHIEF	_	_	_	_	cf1[18]	_	_
4-2	251-260	COMPLAINT	_	_	_	_	cf1[18]	_	_
4-3	261-262	:	_	_	_	_	_	_	_

#Text=1. Chronic lymphocytic leukemia ( CLL ) .
5-1	263-265	1.	_	_	_	_	_	_	_
5-2	266-273	Chronic	abstract[287]	giv:inact[287]	_	Chronic_lymphocytic_leukemia[19]	cf1[19]	coref	9-15[28_287]
5-3	274-285	lymphocytic	abstract[287]	giv:inact[287]	_	Chronic_lymphocytic_leukemia[19]	cf1[19]	_	_
5-4	286-294	leukemia	abstract[287]	giv:inact[287]	_	Chronic_lymphocytic_leukemia[19]	cf1[19]	_	_
5-5	295-296	(	abstract[287]	giv:inact[287]	_	_	_	_	_
5-6	297-300	CLL	abstract[287]	giv:inact[287]	_	Chronic_lymphocytic_leukemia[20]	cf1[20]	_	_
5-7	301-302	)	abstract[287]	giv:inact[287]	_	_	_	_	_
5-8	303-304	.	_	_	_	_	_	_	_

#Text=2. Autoimmune hemolytic anemia .
6-1	305-307	2.	_	_	_	_	_	_	_
6-2	308-318	Autoimmune	_	_	_	_	cf1[22]	_	_
6-3	319-328	hemolytic	_	_	_	_	cf1[22]	_	_
6-4	329-335	anemia	_	_	_	_	cf1[22]	_	_
6-5	336-337	.	_	_	_	_	_	_	_

#Text=3. Oral ulcer .
7-1	338-340	3.	_	_	_	_	_	_	_
7-2	341-345	Oral	_	_	_	_	cf1[23]	_	_
7-3	346-351	ulcer	_	_	_	_	cf1[23]	_	_
7-4	352-353	.	_	_	_	_	_	_	_

#Text=HISTORY OF PRESENT ILLNESS :
8-1	354-361	HISTORY	_	_	_	_	cf1[24]	_	_
8-2	362-364	OF	_	_	_	_	cf1[24]	_	_
8-3	365-372	PRESENT	_	_	_	_	cf1[24]|cf2[25]	_	_
8-4	373-380	ILLNESS	_	_	_	_	cf1[24]|cf2[25]	_	_
8-5	381-382	:	_	_	_	_	_	_	_

#Text=The patient is a 72 - year - old gentleman who was diagnosed with chronic lymphocytic leukemia in May 2008 .
9-1	383-386	The	person[26]	giv:inact[26]	sssss[26]	_	cf1[26]	ana	10-1[31_26]
9-2	387-394	patient	person[26]	giv:inact[26]	sssss[26]	_	cf1[26]	_	_
9-3	395-397	is	_	_	_	_	_	_	_
9-4	398-399	a	_	_	_	_	cf1[27]	_	_
9-5	400-402	72	_	_	_	_	cf1[27]	_	_
9-6	403-404	-	_	_	_	_	cf1[27]	_	_
9-7	405-409	year	_	_	_	_	cf1[27]	_	_
9-8	410-411	-	_	_	_	_	cf1[27]	_	_
9-9	412-415	old	_	_	_	_	cf1[27]	_	_
9-10	416-425	gentleman	_	_	_	_	cf1[27]	_	_
9-11	426-429	who	_	_	_	_	cf1[27]	_	_
9-12	430-433	was	_	_	_	_	cf1[27]	_	_
9-13	434-443	diagnosed	_	_	_	_	cf1[27]	_	_
9-14	444-448	with	_	_	_	_	cf1[27]	_	_
9-15	449-456	chronic	abstract[28]	giv:inact[28]	sssss[28]	Chronic_lymphocytic_leukemia[28]	cf1[27]|cf2[28]	coref	10-14[37_28]
9-16	457-468	lymphocytic	abstract[28]	giv:inact[28]	sssss[28]	Chronic_lymphocytic_leukemia[28]	cf1[27]|cf2[28]	_	_
9-17	469-477	leukemia	abstract[28]	giv:inact[28]	sssss[28]	Chronic_lymphocytic_leukemia[28]	cf1[27]|cf2[28]	_	_
9-18	478-480	in	_	_	_	_	cf1[27]	_	_
9-19	481-484	May	_	_	_	_	cf1[27]|cf3[29]	_	_
9-20	485-489	2008	_	_	_	_	cf1[27]|cf3[29]|cf4[30]	_	_
9-21	490-491	.	_	_	_	_	_	_	_

#Text=He was noted to have autoimmune hemolytic anemia at the time of his CLL diagnosis .
10-1	492-494	He	person[31]	giv:act[31]	sssss[31]	_	cf1*[31]	ana	10-13[36_31]
10-2	495-498	was	_	_	_	_	_	_	_
10-3	499-504	noted	_	_	_	_	_	_	_
10-4	505-507	to	_	_	_	_	_	_	_
10-5	508-512	have	_	_	_	_	_	_	_
10-6	513-523	autoimmune	_	_	_	_	cf3[34]	_	_
10-7	524-533	hemolytic	_	_	_	_	cf3[34]	_	_
10-8	534-540	anemia	_	_	_	_	cf3[34]	_	_
10-9	541-543	at	_	_	_	_	_	_	_
10-10	544-547	the	_	_	_	_	_	_	_
10-11	548-552	time	_	_	_	_	_	_	_
10-12	553-555	of	_	_	_	_	_	_	_
10-13	556-559	his	abstract[35]|person[36]	giv:inact[35]|giv:act[36]	nnnnn[35]|sssss[36]	_	cf4[35]|cf1*[36]	ana	11-1[38_36]
10-14	560-563	CLL	abstract[35]|abstract[37]	giv:inact[35]|giv:act[37]	nnnnn[35]|sssss[37]	Chronic_lymphocytic_leukemia[37]	cf4[35]|cf2[37]	_	_
10-15	564-573	diagnosis	abstract[35]	giv:inact[35]	nnnnn[35]	_	cf4[35]	_	_
10-16	574-575	.	_	_	_	_	_	_	_

#Text=He has been on chronic steroids to control his hemolysis and is currently on prednisone 5 mg every other day .
11-1	576-578	He	person[38]	giv:act[38]	sssss[38]	_	cf1*[38]	ana	11-9[44_38]
11-2	579-582	has	_	_	_	_	_	_	_
11-3	583-587	been	_	_	_	_	_	_	_
11-4	588-590	on	_	_	_	_	_	_	_
11-5	591-598	chronic	_	_	_	_	cf4[42]	_	_
11-6	599-607	steroids	_	_	_	_	cf4[42]	_	_
11-7	608-610	to	_	_	_	_	_	_	_
11-8	611-618	control	_	_	_	_	_	_	_
11-9	619-622	his	person[44]	giv:act[44]	sssss[44]	_	cf2[43]|cf1*[44]	ana	12-1[50_44]
11-10	623-632	hemolysis	_	_	_	_	cf2[43]	_	_
11-11	633-636	and	_	_	_	_	_	_	_
11-12	637-639	is	_	_	_	_	_	_	_
11-13	640-649	currently	_	_	_	_	_	_	_
11-14	650-652	on	_	_	_	_	_	_	_
11-15	653-663	prednisone	_	_	_	_	cf5[45]	_	_
11-16	664-665	5	_	_	_	_	cf6[48]	_	_
11-17	666-668	mg	_	_	_	_	cf6[48]	_	_
11-18	669-674	every	time[49]	new[49]	snnnn[49]	_	cf3[49]	coref	51-12[238_49]
11-19	675-680	other	time[49]	new[49]	snnnn[49]	_	cf3[49]	_	_
11-20	681-684	day	time[49]	new[49]	snnnn[49]	_	cf3[49]	_	_
11-21	685-686	.	_	_	_	_	_	_	_

#Text=He comes in to clinic today for follow - up and complete blood count .
12-1	687-689	He	person[50]	giv:act[50]	sssss[50]	_	cf1*[50]	ana	13-2[58_50]
12-2	690-695	comes	_	_	_	_	_	_	_
12-3	696-698	in	_	_	_	_	_	_	_
12-4	699-701	to	_	_	_	_	_	_	_
12-5	702-708	clinic	_	_	_	_	cf2[51]	_	_
12-6	709-714	today	_	_	_	_	cf3[52]	_	_
12-7	715-718	for	_	_	_	_	_	_	_
12-8	719-725	follow	_	_	_	_	cf4[56]	_	_
12-9	726-727	-	_	_	_	_	cf4[56]	_	_
12-10	728-730	up	_	_	_	_	cf4[56]	_	_
12-11	731-734	and	_	_	_	_	cf4[56]	_	_
12-12	735-743	complete	_	_	_	_	cf4[56]	_	_
12-13	744-749	blood	_	_	_	_	cf4[56]	_	_
12-14	750-755	count	_	_	_	_	cf4[56]	_	_
12-15	756-757	.	_	_	_	_	_	_	_

#Text=At his last office visit we discontinued this prophylactic antivirals and antibacterial .
13-1	758-760	At	_	_	_	_	_	_	_
13-2	761-764	his	person[58]	giv:act[58]	sssss[58]	_	cf4[57]|cf1*[58]	coref	19-1[90_58]
13-3	765-769	last	_	_	_	_	cf4[57]	_	_
13-4	770-776	office	_	_	_	_	cf4[57]|cf5[59]	_	_
13-5	777-782	visit	_	_	_	_	cf4[57]	_	_
13-6	783-785	we	person[60]	acc:com[60]	nnnnn[60]	_	cf2[60]	ana	52-1[239_60]
13-7	786-798	discontinued	_	_	_	_	_	_	_
13-8	799-803	this	_	_	_	_	cf3[64]	_	_
13-9	804-816	prophylactic	_	_	_	_	cf3[64]	_	_
13-10	817-827	antivirals	_	_	_	_	cf3[64]	_	_
13-11	828-831	and	_	_	_	_	cf3[64]	_	_
13-12	832-845	antibacterial	_	_	_	_	cf3[64]	_	_
13-13	846-847	.	_	_	_	_	_	_	_

#Text=CURRENT MEDICATIONS :
14-1	848-855	CURRENT	_	_	_	_	cf1[65]	_	_
14-2	856-867	MEDICATIONS	_	_	_	_	cf1[65]	_	_
14-3	868-869	:	_	_	_	_	_	_	_

#Text=Prilosec 20 mg b.i.d. , levothyroxine 50 mcg q.d. , Lopressor 75 mg q.d. , vitamin C 500 mg q.d. , multivitamin q.d. , simvastatin 20 mg q.d. , and prednisone 5 mg q.o.d.
15-1	870-878	Prilosec	_	_	_	Omeprazole[66]	cf5[66]	_	_
15-2	879-881	20	_	_	_	_	cf1[68]	_	_
15-3	882-884	mg	_	_	_	_	cf1[68]	_	_
15-4	885-891	b.i.d.	_	_	_	_	_	_	_
15-5	892-893	,	_	_	_	_	_	_	_
15-6	894-907	levothyroxine	_	_	_	_	cf6[69]	_	_
15-7	908-910	50	_	_	_	_	cf7[71]	_	_
15-8	911-914	mcg	_	_	_	_	cf7[71]	_	_
15-9	915-919	q.d.	_	_	_	_	_	_	_
15-10	920-921	,	_	_	_	_	_	_	_
15-11	922-931	Lopressor	_	_	_	Metoprolol[72]	cf4[72]	_	_
15-12	932-934	75	_	_	_	_	cf8[74]	_	_
15-13	935-937	mg	_	_	_	_	cf8[74]	_	_
15-14	938-942	q.d.	_	_	_	_	_	_	_
15-15	943-944	,	_	_	_	_	_	_	_
15-16	945-952	vitamin	_	_	_	Vitamin_C[75]	cf9[75]	_	_
15-17	953-954	C	_	_	_	Vitamin_C[75]	cf9[75]	_	_
15-18	955-958	500	_	_	_	_	cf10[76]	_	_
15-19	959-961	mg	_	_	_	_	cf10[76]	_	_
15-20	962-966	q.d.	_	_	_	_	_	_	_
15-21	967-968	,	_	_	_	_	_	_	_
15-22	969-981	multivitamin	_	_	_	_	cf11[77]	_	_
15-23	982-986	q.d.	_	_	_	_	_	_	_
15-24	987-988	,	_	_	_	_	_	_	_
15-25	989-1000	simvastatin	_	_	_	_	cf12[78]	_	_
15-26	1001-1003	20	_	_	_	_	cf1[81]	_	_
15-27	1004-1006	mg	_	_	_	_	cf1[81]	_	_
15-28	1007-1011	q.d.	_	_	_	_	_	_	_
15-29	1012-1013	,	_	_	_	_	_	_	_
15-30	1014-1017	and	_	_	_	_	_	_	_
15-31	1018-1028	prednisone	_	_	_	_	cf2[82]	_	_
15-32	1029-1030	5	_	_	_	_	cf3[84]	_	_
15-33	1031-1033	mg	_	_	_	_	cf3[84]	_	_
15-34	1034-1040	q.o.d.	_	_	_	_	_	_	_

#Text=ALLERGIES :
16-1	1041-1050	ALLERGIES	_	_	_	_	cf1[85]	_	_
16-2	1051-1052	:	_	_	_	_	_	_	_

#Text=Vicodin .
17-1	1053-1060	Vicodin	_	_	_	Hydrocodone/paracetamol[86]	cf1[86]	_	_
17-2	1061-1062	.	_	_	_	_	_	_	_

#Text=REVIEW OF SYSTEMS :
18-1	1063-1069	REVIEW	_	_	_	_	cf1[89]	_	_
18-2	1070-1072	OF	_	_	_	_	cf1[89]	_	_
18-3	1073-1080	SYSTEMS	_	_	_	_	cf1[89]	_	_
18-4	1081-1082	:	_	_	_	_	_	_	_

#Text=The patient reports ulcer on his tongue and his lip .
19-1	1083-1086	The	person[90]	giv:inact[90]	sssss[90]	_	cf1[90]	ana	19-6[93_90]
19-2	1087-1094	patient	person[90]	giv:inact[90]	sssss[90]	_	cf1[90]	_	_
19-3	1095-1102	reports	_	_	_	_	_	_	_
19-4	1103-1108	ulcer	_	_	_	_	cf2[91]	_	_
19-5	1109-1111	on	_	_	_	_	cf2[91]	_	_
19-6	1112-1115	his	object[92]|person[93]	new[92]|giv:act[93]	snnnn[92]|sssss[93]	_	cf2[91]|cf3[92]|cf1[93]	ana|coref	19-9[96_93]|36-8[170_92]
19-7	1116-1122	tongue	object[92]	new[92]	snnnn[92]	_	cf2[91]|cf3[92]	_	_
19-8	1123-1126	and	_	_	_	_	cf2[91]	_	_
19-9	1127-1130	his	person[96]	giv:act[96]	sssss[96]	_	cf2[91]|cf4[95]|cf1[96]	ana	20-1[97_96]
19-10	1131-1134	lip	_	_	_	_	cf2[91]|cf4[95]	_	_
19-11	1135-1136	.	_	_	_	_	_	_	_

#Text=He has been off of Valtrex for five days .
20-1	1137-1139	He	person[97]	giv:act[97]	sssss[97]	_	cf1*[97]	ana	21-1[103_97]
20-2	1140-1143	has	_	_	_	_	_	_	_
20-3	1144-1148	been	_	_	_	_	_	_	_
20-4	1149-1152	off	_	_	_	_	_	_	_
20-5	1153-1155	of	_	_	_	_	_	_	_
20-6	1156-1163	Valtrex	substance[98]	new[98]	sssns[98]	_	cf2[98]	coref	52-9[243_98]
20-7	1164-1167	for	_	_	_	_	_	_	_
20-8	1168-1172	five	_	_	_	_	cf3[102]	_	_
20-9	1173-1177	days	_	_	_	_	cf3[102]	_	_
20-10	1178-1179	.	_	_	_	_	_	_	_

#Text=He is having some difficulty with his night vision with his left eye .
21-1	1180-1182	He	person[103]	giv:act[103]	sssss[103]	_	cf1*[103]	ana	21-7[107_103]
21-2	1183-1185	is	_	_	_	_	_	_	_
21-3	1186-1192	having	_	_	_	_	_	_	_
21-4	1193-1197	some	_	_	_	_	cf2[105]	_	_
21-5	1198-1208	difficulty	_	_	_	_	cf2[105]	_	_
21-6	1209-1213	with	_	_	_	_	cf2[105]	_	_
21-7	1214-1217	his	person[107]	giv:act[107]	sssss[107]	_	cf2[105]|cf3[106]|cf1*[107]	ana	21-11[110_107]
21-8	1218-1223	night	_	_	_	_	cf2[105]|cf3[106]	_	_
21-9	1224-1230	vision	_	_	_	_	cf2[105]|cf3[106]	_	_
21-10	1231-1235	with	_	_	_	_	cf2[105]	_	_
21-11	1236-1239	his	person[110]	giv:act[110]	sssss[110]	_	cf2[105]|cf4[109]|cf1*[110]	ana	22-1[111_110]
21-12	1240-1244	left	_	_	_	_	cf2[105]|cf4[109]	_	_
21-13	1245-1248	eye	_	_	_	_	cf2[105]|cf4[109]	_	_
21-14	1249-1250	.	_	_	_	_	_	_	_

#Text=He has a known cataract .
22-1	1251-1253	He	person[111]	giv:act[111]	sssss[111]	_	cf1*[111]	ana	23-1[115_111]
22-2	1254-1257	has	_	_	_	_	_	_	_
22-3	1258-1259	a	_	_	_	_	cf2[114]	_	_
22-4	1260-1265	known	_	_	_	_	cf2[114]	_	_
22-5	1266-1274	cataract	_	_	_	_	cf2[114]	_	_
22-6	1275-1276	.	_	_	_	_	_	_	_

#Text=He denies any fevers , chills , or night sweats .
23-1	1277-1279	He	person[115]	giv:act[115]	sssss[115]	_	cf1*[115]	ana	24-1[124_115]
23-2	1280-1286	denies	_	_	_	_	_	_	_
23-3	1287-1290	any	_	_	_	_	cf2[117]	_	_
23-4	1291-1297	fevers	_	_	_	_	cf2[117]|cf3[118]	_	_
23-5	1298-1299	,	_	_	_	_	cf2[117]	_	_
23-6	1300-1306	chills	_	_	_	_	cf2[117]|cf4[119]	_	_
23-7	1307-1308	,	_	_	_	_	cf2[117]	_	_
23-8	1309-1311	or	_	_	_	_	cf2[117]	_	_
23-9	1312-1317	night	_	_	_	_	cf2[117]|cf5[122]|cf6[123]	_	_
23-10	1318-1324	sweats	_	_	_	_	cf2[117]|cf5[122]	_	_
23-11	1325-1326	.	_	_	_	_	_	_	_

#Text=He continues to have headaches .
24-1	1327-1329	He	person[124]	giv:act[124]	sssss[124]	_	cf1*[124]	ana	25-4[131_124]
24-2	1330-1339	continues	_	_	_	_	_	_	_
24-3	1340-1342	to	_	_	_	_	_	_	_
24-4	1343-1347	have	_	_	_	_	_	_	_
24-5	1348-1357	headaches	_	_	_	_	cf2[125]	_	_
24-6	1358-1359	.	_	_	_	_	_	_	_

#Text=The rest of his review of systems is negative .
25-1	1360-1363	The	_	_	_	_	cf2[129]	_	_
25-2	1364-1368	rest	_	_	_	_	cf2[129]	_	_
25-3	1369-1371	of	_	_	_	_	cf2[129]	_	_
25-4	1372-1375	his	person[131]	giv:act[131]	sssss[131]	_	cf2[129]|cf3[130]|cf1*[131]	ana	32-1[151_131]
25-5	1376-1382	review	_	_	_	_	cf2[129]|cf3[130]	_	_
25-6	1383-1385	of	_	_	_	_	cf2[129]|cf3[130]	_	_
25-7	1386-1393	systems	_	_	_	_	cf2[129]|cf3[130]|cf4[132]	_	_
25-8	1394-1396	is	_	_	_	_	_	_	_
25-9	1397-1405	negative	_	_	_	_	_	_	_
25-10	1406-1407	.	_	_	_	_	_	_	_

#Text=PHYSICAL EXAM :
26-1	1408-1416	PHYSICAL	_	_	_	_	cf1[135]	_	_
26-2	1417-1421	EXAM	_	_	_	_	cf1[135]	_	_
26-3	1422-1423	:	_	_	_	_	_	_	_

#Text=VITALS : BP : 120 / 74 .
27-1	1424-1430	VITALS	_	_	_	_	cf2[136]	_	_
27-2	1431-1432	:	_	_	_	_	_	_	_
27-3	1433-1435	BP	_	_	_	Blood_pressure[137]	cf1[137]	_	_
27-4	1436-1437	:	_	_	_	_	_	_	_
27-5	1438-1441	120	_	_	_	Blood_pressure[140]	cf1[140]	_	_
27-6	1442-1443	/	_	_	_	Blood_pressure[140]	cf1[140]	_	_
27-7	1444-1446	74	_	_	_	Blood_pressure[140]	cf1[140]	_	_
27-8	1447-1448	.	_	_	_	_	_	_	_

#Text=HEART RATE : 72 .
28-1	1449-1454	HEART	_	_	_	_	cf1[141]	_	_
28-2	1455-1459	RATE	_	_	_	_	cf1[141]	_	_
28-3	1460-1461	:	_	_	_	_	_	_	_
28-4	1462-1464	72	_	_	_	_	cf1[142]	_	_
28-5	1465-1466	.	_	_	_	_	_	_	_

#Text=TEMP : 97.8 .
29-1	1467-1471	TEMP	_	_	_	_	cf1[143]	_	_
29-2	1472-1473	:	_	_	_	_	_	_	_
29-3	1474-1478	97.8	_	_	_	_	cf1[144]	_	_
29-4	1479-1480	.	_	_	_	_	_	_	_

#Text=Weight : 112.7 kg .
30-1	1481-1487	Weight	_	_	_	_	cf1[145]	_	_
30-2	1488-1489	:	_	_	_	_	_	_	_
30-3	1490-1495	112.7	_	_	_	_	cf1[150]	_	_
30-4	1496-1498	kg	_	_	_	_	cf1[150]	_	_
30-5	1499-1500	.	_	_	_	_	_	_	_

#Text=GEN :
31-1	1501-1504	GEN	_	_	_	_	_	_	_
31-2	1505-1506	:	_	_	_	_	_	_	_

#Text=He has a obvious cold sore on his bottom lip on the left .
32-1	1507-1509	He	person[151]	giv:inact[151]	sssss[151]	_	cf1[151]	ana	32-8[155_151]
32-2	1510-1513	has	_	_	_	_	_	_	_
32-3	1514-1515	a	_	_	_	_	cf2[153]	_	_
32-4	1516-1523	obvious	_	_	_	_	cf2[153]	_	_
32-5	1524-1528	cold	_	_	_	_	cf2[153]	_	_
32-6	1529-1533	sore	_	_	_	_	cf2[153]	_	_
32-7	1534-1536	on	_	_	_	_	cf2[153]	_	_
32-8	1537-1540	his	person[155]	giv:act[155]	sssss[155]	_	cf2[153]|cf4[154]|cf1[155]	ana	36-1[167_155]
32-9	1541-1547	bottom	_	_	_	_	cf2[153]|cf4[154]	_	_
32-10	1548-1551	lip	_	_	_	_	cf2[153]|cf4[154]	_	_
32-11	1552-1554	on	_	_	_	_	cf2[153]	_	_
32-12	1555-1558	the	_	_	_	_	cf2[153]|cf3[157]	_	_
32-13	1559-1563	left	_	_	_	_	cf2[153]|cf3[157]	_	_
32-14	1564-1565	.	_	_	_	_	_	_	_

#Text=HEENT :
33-1	1566-1571	HEENT	_	_	_	_	cf1[158]	_	_
33-2	1572-1573	:	_	_	_	_	_	_	_

#Text=Pupils are equal , round , and reactive to light .
34-1	1574-1580	Pupils	_	_	_	_	cf1[159]	_	_
34-2	1581-1584	are	_	_	_	_	_	_	_
34-3	1585-1590	equal	_	_	_	_	_	_	_
34-4	1591-1592	,	_	_	_	_	_	_	_
34-5	1593-1598	round	_	_	_	_	_	_	_
34-6	1599-1600	,	_	_	_	_	_	_	_
34-7	1601-1604	and	_	_	_	_	_	_	_
34-8	1605-1613	reactive	_	_	_	_	_	_	_
34-9	1614-1616	to	_	_	_	_	_	_	_
34-10	1617-1622	light	_	_	_	_	cf2[160]	_	_
34-11	1623-1624	.	_	_	_	_	_	_	_

#Text=Sclerae are anicteric .
35-1	1625-1632	Sclerae	_	_	_	_	cf1[161]	_	_
35-2	1633-1636	are	_	_	_	_	_	_	_
35-3	1637-1646	anicteric	_	_	_	_	_	_	_
35-4	1647-1648	.	_	_	_	_	_	_	_

#Text=His oropharynx is notable for ulcer on his tongue .
36-1	1649-1652	His	person[167]	giv:inact[167]	sssss[167]	_	cf4[166]|cf1[167]	ana	36-8[171_167]
36-2	1653-1663	oropharynx	_	_	_	_	cf4[166]	_	_
36-3	1664-1666	is	_	_	_	_	_	_	_
36-4	1667-1674	notable	_	_	_	_	_	_	_
36-5	1675-1678	for	_	_	_	_	_	_	_
36-6	1679-1684	ulcer	_	_	_	_	cf2[169]	_	_
36-7	1685-1687	on	_	_	_	_	cf2[169]	_	_
36-8	1688-1691	his	object[170]|person[171]	giv:inact[170]|giv:act[171]	snnnn[170]|sssss[171]	_	cf2[169]|cf3[170]|cf1[171]	ana	37-4[175_171]
36-9	1692-1698	tongue	object[170]	giv:inact[170]	snnnn[170]	_	cf2[169]|cf3[170]	_	_
36-10	1699-1700	.	_	_	_	_	_	_	_

#Text=No ulcers on his buccal mucosa .
37-1	1701-1703	No	_	_	_	_	cf2[173]	_	_
37-2	1704-1710	ulcers	_	_	_	_	cf2[173]	_	_
37-3	1711-1713	on	_	_	_	_	cf2[173]	_	_
37-4	1714-1717	his	person[175]	giv:act[175]	sssss[175]	_	cf2[173]|cf3[174]|cf1*[175]	ana	39-1[177_175]
37-5	1718-1724	buccal	_	_	_	_	cf2[173]|cf3[174]	_	_
37-6	1725-1731	mucosa	_	_	_	_	cf2[173]|cf3[174]	_	_
37-7	1732-1733	.	_	_	_	_	_	_	_

#Text=NECK : Supple .
38-1	1734-1738	NECK	_	_	_	_	cf1[176]	_	_
38-2	1739-1740	:	_	_	_	_	_	_	_
38-3	1741-1747	Supple	_	_	_	_	_	_	_
38-4	1748-1749	.	_	_	_	_	_	_	_

#Text=He has no cervical or supraclavicular adenopathy .
39-1	1750-1752	He	person[177]	giv:inact[177]	sssss[177]	_	cf1[177]	ana	44-1[191_177]
39-2	1753-1756	has	_	_	_	_	_	_	_
39-3	1757-1759	no	_	_	_	_	_	_	_
39-4	1760-1768	cervical	_	_	_	_	cf2[181]	_	_
39-5	1769-1771	or	_	_	_	_	cf2[181]	_	_
39-6	1772-1787	supraclavicular	_	_	_	_	cf2[181]	_	_
39-7	1788-1798	adenopathy	_	_	_	_	cf2[181]	_	_
39-8	1799-1800	.	_	_	_	_	_	_	_

#Text=LUNGS :
40-1	1801-1806	LUNGS	_	_	_	_	cf1[182]	_	_
40-2	1807-1808	:	_	_	_	_	_	_	_

#Text=Clear to auscultation bilaterally .
41-1	1809-1814	Clear	_	_	_	_	_	_	_
41-2	1815-1817	to	_	_	_	_	_	_	_
41-3	1818-1830	auscultation	_	_	_	_	cf1[183]	_	_
41-4	1831-1842	bilaterally	_	_	_	_	_	_	_
41-5	1843-1844	.	_	_	_	_	_	_	_

#Text=CV : Regular rate ; normal S1 , S2 , no murmurs .
42-1	1845-1847	CV	_	_	_	_	_	_	_
42-2	1848-1849	:	_	_	_	_	_	_	_
42-3	1850-1857	Regular	_	_	_	_	cf1[186]	_	_
42-4	1858-1862	rate	_	_	_	_	cf1[186]	_	_
42-5	1863-1864	;	_	_	_	_	_	_	_
42-6	1865-1871	normal	_	_	_	_	cf2[187]	_	_
42-7	1872-1874	S1	_	_	_	_	cf2[187]	_	_
42-8	1875-1876	,	_	_	_	_	_	_	_
42-9	1877-1879	S2	_	_	_	_	cf3[188]	_	_
42-10	1880-1881	,	_	_	_	_	_	_	_
42-11	1882-1884	no	_	_	_	_	_	_	_
42-12	1885-1892	murmurs	_	_	_	_	cf4[189]	_	_
42-13	1893-1894	.	_	_	_	_	_	_	_

#Text=ABDOMEN : Soft .
43-1	1895-1902	ABDOMEN	_	_	_	_	cf1[190]	_	_
43-2	1903-1904	:	_	_	_	_	_	_	_
43-3	1905-1909	Soft	_	_	_	_	_	_	_
43-4	1910-1911	.	_	_	_	_	_	_	_

#Text=He has positive bowel sounds .
44-1	1912-1914	He	person[191]	giv:inact[191]	sssss[191]	_	cf1[191]	ana	48-1[207_191]
44-2	1915-1918	has	_	_	_	_	_	_	_
44-3	1919-1927	positive	_	_	_	_	cf2[196]	_	_
44-4	1928-1933	bowel	_	_	_	_	cf2[196]|cf3[197]	_	_
44-5	1934-1940	sounds	_	_	_	_	cf2[196]	_	_
44-6	1941-1942	.	_	_	_	_	_	_	_

#Text=No hepatosplenomegaly .
45-1	1943-1945	No	_	_	_	_	_	_	_
45-2	1946-1964	hepatosplenomegaly	_	_	_	_	cf1[198]	_	_
45-3	1965-1966	.	_	_	_	_	_	_	_

#Text=EXT : No lower extremity edema .
46-1	1967-1970	EXT	_	_	_	_	_	_	_
46-2	1971-1972	:	_	_	_	_	_	_	_
46-3	1973-1975	No	_	_	_	_	_	_	_
46-4	1976-1981	lower	_	_	_	_	cf1[201]	_	_
46-5	1982-1991	extremity	_	_	_	_	cf1[201]	_	_
46-6	1992-1997	edema	_	_	_	_	cf1[201]|cf2[202]	_	_
46-7	1998-1999	.	_	_	_	_	_	_	_

#Text=LABORATORY DATA :
47-1	2000-2010	LABORATORY	_	_	_	_	cf1[204]	_	_
47-2	2011-2015	DATA	_	_	_	_	cf1[204]	_	_
47-3	2016-2017	:	_	_	_	_	_	_	_

#Text=His white blood cell count is 4.6 , hemoglobin 14.2 , hematocrit 42 , and platelets 207,000 .
48-1	2018-2021	His	person[207]	giv:inact[207]	sssss[207]	_	cf1[205]|cf6[206]|cf5[207]	ana	50-1[225_207]
48-2	2022-2027	white	_	_	_	_	cf1[205]|cf6[206]	_	_
48-3	2028-2033	blood	_	_	_	_	cf1[205]|cf6[206]	_	_
48-4	2034-2038	cell	_	_	_	_	cf1[205]|cf6[206]	_	_
48-5	2039-2044	count	_	_	_	_	cf1[205]	_	_
48-6	2045-2047	is	_	_	_	_	_	_	_
48-7	2048-2051	4.6	_	_	_	_	cf1[208]	_	_
48-8	2052-2053	,	_	_	_	_	_	_	_
48-9	2054-2064	hemoglobin	_	_	_	_	cf2[209]	_	_
48-10	2065-2069	14.2	_	_	_	_	cf2[210]	_	_
48-11	2070-2071	,	_	_	_	_	_	_	_
48-12	2072-2082	hematocrit	_	_	_	_	cf3[211]	_	_
48-13	2083-2085	42	_	_	_	_	cf3[212]	_	_
48-14	2086-2087	,	_	_	_	_	_	_	_
48-15	2088-2091	and	_	_	_	_	_	_	_
48-16	2092-2101	platelets	_	_	_	_	cf4[213]	_	_
48-17	2102-2109	207,000	_	_	_	_	cf4[214]	_	_
48-18	2110-2111	.	_	_	_	_	_	_	_

#Text=ASSESSMENT / PLAN :
49-1	2112-2122	ASSESSMENT	_	_	_	_	cf1[223]	_	_
49-2	2123-2124	/	_	_	_	_	cf1[223]	_	_
49-3	2125-2129	PLAN	_	_	_	_	cf1[223]|cf2[224]	_	_
49-4	2130-2131	:	_	_	_	_	_	_	_

#Text=This is a 72 - year - old gentleman with chronic lymphocytic leukemia on chronic steroids for autoimmune hemolytic anemia .
50-1	2132-2136	This	person[225]	giv:inact[225]	sssss[225]	_	cf1[225]	ana	51-1[234_225]
50-2	2137-2139	is	_	_	_	_	_	_	_
50-3	2140-2141	a	_	_	_	_	cf1[228]	_	_
50-4	2142-2144	72	_	_	_	_	cf1[228]	_	_
50-5	2145-2146	-	_	_	_	_	cf1[228]	_	_
50-6	2147-2151	year	_	_	_	_	cf1[228]	_	_
50-7	2152-2153	-	_	_	_	_	cf1[228]	_	_
50-8	2154-2157	old	_	_	_	_	cf1[228]	_	_
50-9	2158-2167	gentleman	_	_	_	_	cf1[228]	_	_
50-10	2168-2172	with	_	_	_	_	cf1[228]	_	_
50-11	2173-2180	chronic	_	_	_	Chronic_lymphocytic_leukemia[229]	cf1[228]|cf2[229]	_	_
50-12	2181-2192	lymphocytic	_	_	_	Chronic_lymphocytic_leukemia[229]	cf1[228]|cf2[229]	_	_
50-13	2193-2201	leukemia	_	_	_	Chronic_lymphocytic_leukemia[229]	cf1[228]|cf2[229]	_	_
50-14	2202-2204	on	_	_	_	_	cf1[228]	_	_
50-15	2205-2212	chronic	substance[230]	new[230]	sssss[230]	_	cf1[228]|cf4[230]	coref	52-13[244_230]
50-16	2213-2221	steroids	substance[230]	new[230]	sssss[230]	_	cf1[228]|cf4[230]	_	_
50-17	2222-2225	for	_	_	_	_	cf1[228]	_	_
50-18	2226-2236	autoimmune	_	_	_	_	cf1[228]|cf3[231]	_	_
50-19	2237-2246	hemolytic	_	_	_	_	cf1[228]|cf3[231]	_	_
50-20	2247-2253	anemia	_	_	_	_	cf1[228]|cf3[231]	_	_
50-21	2254-2255	.	_	_	_	_	_	_	_

#Text=His blood counts are relatively stable at 5 mg of prednisone every other day .
51-1	2256-2259	His	person[234]	giv:act[234]	sssss[234]	_	cf6[232]|cf4[233]|cf1*[234]	ana	52-6[240_234]
51-2	2260-2265	blood	_	_	_	_	cf6[232]|cf4[233]	_	_
51-3	2266-2272	counts	_	_	_	_	cf6[232]|cf4[233]	_	_
51-4	2273-2276	are	_	_	_	_	cf6[232]	_	_
51-5	2277-2287	relatively	_	_	_	_	cf6[232]	_	_
51-6	2288-2294	stable	_	_	_	_	cf6[232]	_	_
51-7	2295-2297	at	_	_	_	_	cf6[232]	_	_
51-8	2298-2299	5	_	_	_	_	cf6[232]|cf5[236]|cf3[237]	_	_
51-9	2300-2302	mg	_	_	_	_	cf6[232]|cf5[236]|cf3[237]	_	_
51-10	2303-2305	of	_	_	_	_	cf6[232]|cf5[236]	_	_
51-11	2306-2316	prednisone	_	_	_	_	cf6[232]|cf5[236]	_	_
51-12	2317-2322	every	time[238]	giv:inact[238]	snnnn[238]	_	cf6[232]|cf2[238]	_	_
51-13	2323-2328	other	time[238]	giv:inact[238]	snnnn[238]	_	cf6[232]|cf2[238]	_	_
51-14	2329-2332	day	time[238]	giv:inact[238]	snnnn[238]	_	cf6[232]|cf2[238]	_	_
51-15	2333-2334	.	_	_	_	_	_	_	_

#Text=We will plan on putting him back on the Valtrex and decreasing his steroids to 1 mg daily .
52-1	2335-2337	We	person[239]	giv:inact[239]	nnnnn[239]	_	cf2[239]	_	_
52-2	2338-2342	will	_	_	_	_	_	_	_
52-3	2343-2347	plan	_	_	_	_	_	_	_
52-4	2348-2350	on	_	_	_	_	_	_	_
52-5	2351-2358	putting	_	_	_	_	_	_	_
52-6	2359-2362	him	person[240]	giv:act[240]	sssss[240]	_	cf1*[240]	ana	52-13[245_240]
52-7	2363-2367	back	_	_	_	_	_	_	_
52-8	2368-2370	on	_	_	_	_	_	_	_
52-9	2371-2374	the	substance[243]	giv:inact[243]	sssns[243]	_	cf4[243]	_	_
52-10	2375-2382	Valtrex	substance[243]	giv:inact[243]	sssns[243]	_	cf4[243]	_	_
52-11	2383-2386	and	_	_	_	_	_	_	_
52-12	2387-2397	decreasing	_	_	_	_	_	_	_
52-13	2398-2401	his	substance[244]|person[245]	giv:inact[244]|giv:act[245]	sssss[244]|sssss[245]	_	cf3[244]|cf1*[245]	ana	53-4[249_245]
52-14	2402-2410	steroids	substance[244]	giv:inact[244]	sssss[244]	_	cf3[244]	_	_
52-15	2411-2413	to	_	_	_	_	_	_	_
52-16	2414-2415	1	_	_	_	_	cf5[247]	_	_
52-17	2416-2418	mg	_	_	_	_	cf5[247]	_	_
52-18	2419-2424	daily	_	_	_	_	_	_	_
52-19	2425-2426	.	_	_	_	_	_	_	_

#Text=I will see him back in clinic in a week .
53-1	2427-2428	I	_	_	_	_	cf3[248]	_	_
53-2	2429-2433	will	_	_	_	_	_	_	_
53-3	2434-2437	see	_	_	_	_	_	_	_
53-4	2438-2441	him	person[249]	giv:act[249]	sssss[249]	_	cf1*[249]	_	_
53-5	2442-2446	back	_	_	_	_	_	_	_
53-6	2447-2449	in	_	_	_	_	_	_	_
53-7	2450-2456	clinic	_	_	_	_	cf2[250]	_	_
53-8	2457-2459	in	_	_	_	_	_	_	_
53-9	2460-2461	a	_	_	_	_	cf4[254]	_	_
53-10	2462-2466	week	_	_	_	_	cf4[254]	_	_
53-11	2467-2468	.	_	_	_	_	_	_	_

